Jones Trading downgraded shares of Theratechnologies (TSE:TH - Free Report) from a strong-buy rating to a hold rating in a research report released on Thursday,Zacks.com reports.
Theratechnologies Stock Performance
TH traded down C$0.05 during trading on Thursday, reaching C$4.18. 154,712 shares of the company were exchanged, compared to its average volume of 93,326. The stock has a market cap of C$133.36 million, a P/E ratio of -47.32, a PEG ratio of -8.50 and a beta of 1.73. The firm has a 50 day moving average of C$3.59 and a 200 day moving average of C$2.89. The company has a current ratio of 1.08, a quick ratio of 0.64 and a debt-to-equity ratio of -293.92. Theratechnologies has a 52 week low of C$1.59 and a 52 week high of C$4.33.
Theratechnologies Company Profile
(
Get Free Report)
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
See Also
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
